Clinical Trial - Trial jRCT2071230059
Access comprehensive clinical trial information for jRCT2071230059 through Pure Global AI's free database. This phase not specified trial is sponsored by Otsuka Pharmaceutical Co., LTD. and is currently Recruiting. The study focuses on schizophrenia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2071230059
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2071230059
Untitled Trial
A multicenter, randomized, open label, 2 arm, 2 period crossover trial to investigate the effects of food on the pharmacokinetics of a single dose of brexpiprazole once weekly (QW) formulation in patients with schizophrenia
Study Focus
Interventional
Sponsor & Location
Otsuka Pharmaceutical Co., LTD.
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Schizophrenia
Simple schizophrenia
Schizophrenia, unspecified
Other schizophrenia
Paranoid schizophrenia
Data Source
Japan Registry Clinical Trial
jRCT2071230059
Non-Device Trial